Bond for Life
The race to develop the next new drug drives pharmaceutical and biotechnology companies and their scientists to stay up-to-date on all the latest research and technology. That’s why ACS publications are a must-read among professionals working to better understand molecular structure and biological activity.
With more than 7.5 million annual home page views, the ACS collection of pharmaceutical and life science-related publications is already capturing the attention of your target audience. More than 50% of readers hold doctorates in their respective fields, and more than 86% of readers hold purchasing power. And you can bond with them, with an effective ACS digital strategy customized to meet your needs.
Target Your Audience
- More than 100,000 eTOC alert subscribers
- Delivering over 7 million impressions monthly
- 52% of readers hold a doctorate or post doctoral
- 43% of readers plan to purchase chromatography products in the
next 12 months - 67% of readers work in R&D
- 46% of C&EN readers work in the pharmaceutical and life sciences industries
- Average Budget: $212,000
- 51% Industry vs 49% Academic
Pharma/Life Sciences Channel
Lifelong bonds with your target audience begin when you choose to reach out and start the conversation. Nowhere is that easier to achieve than with ACS’ pharma and life sciences journals. Maximize your ROI by delivering your message across our popular industry-specific publications.
- Accounts of Chemical Research
- ACS Catalysis
- ACS Chemical Biology
- ACS Chemical Neuroscience
- ACS Combinatorial Science
- ACS Medicinal Chemistry Letters